- Article
Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against Acinetobacter baumannii in Patients with Hospital-Acquired Pneumonia
- Yingjie Zhou,
- Jing Zhang,
- Yuancheng Chen,
- Jufang Wu,
- Beining Guo,
- Xiaojie Wu,
- Yingyuan Zhang,
- Minggui Wang,
- Ru Ya and
- Hao Huang
Cefoperazone/sulbactam (CPZ/SUL) is a β-lactam and β-lactamase inhibitor combination therapy for the treatment of respiratory tract infections. Using data from a prospective, multiple-center, open-label clinical trial in 54 patients with ho...

